Navigation Links
Neuroimaging suggests that truthfulness requires no act of will for honest people
Date:7/13/2009

CAMBRIDGE, Mass. A new study of the cognitive processes involved with honesty suggests that truthfulness depends more on absence of temptation than active resistance to temptation.

Using neuroimaging, psychologists looked at the brain activity of people given the chance to gain money dishonestly by lying and found that honest people showed no additional neural activity when telling the truth, implying that extra cognitive processes were not necessary to choose honesty. However, those individuals who behaved dishonestly, even when telling the truth, showed additional activity in brain regions that involve control and attention.

The study is published in Proceedings of the National Academy of Sciences, and was led by Joshua Greene, assistant professor of psychology in the Faculty of Arts and Sciences at Harvard University, along with Joe Paxton, a graduate student in psychology.

"Being honest is not so much a matter of exercising willpower as it is being disposed to behave honestly in a more effortless kind of way," says Greene. "This may not be true for all situations, but it seems to be true for at least this situation."

The research was designed to test two theories about the nature of honesty the "Will" theory, in which honesty results from the active resistance of temptation, and the "Grace" theory in which honesty is a product of lack of temptation. The results of this study suggest that the "Grace" theory is true, because the honest participants did not show any additional neural activity when telling the truth.

To prompt participants to lie, the researchers created a cover story about the focus of their study. The research was presented as a study of paranormal ability to predict the future. Participants were asked to predict the outcomes of a series of coin tosses, and were told that the researchers believed predicting the future was more likely when given a monetary incentive and when the predicti
'/>"/>

Contact: Amy Lavoie
amy_lavoie@harvard.edu
617-496-9982
Harvard University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. New neuroimaging study identifies brain signature for cigarette cravings
2. Researchers use neuroimaging to study ESP
3. Michael J. Fox Foundation Awards $1.9 Million for Development of Non-Invasive Neuroimaging Techniques in Living Brain
4. Alzheimers Disease Neuroimaging Initiative announces completion of genome-wide analysis
5. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
6. New review suggests caution on drugs to raise good cholesterol
7. Preclinical study suggests organ-transplant drug may aid in lupus fight
8. Methamphetamine study suggests increased risk for HIV transmission
9. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
10. Study suggests brain tumors need treatment with multiple targeted drugs
11. RealAge.com Suggests a Reason to Celebrate in September!

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ONGBEACH,Calif.,Nov.25/PRNewswire/--Thanksgivingme...iorsinthegreaterLongBeachareathankstoFaithInAction...denceatHome(IAH),adivisionofSCANHealthPlan.Formore...fvolunteerstodeliverwarmThanksgivingmealstoseniors...thLosAngelesandsurroundingcities. ,, "Ourwarmho...
(Date:11/25/2009)...ANFRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQuali...er Spare the Air Alert forThursday,N...elogsoranyothersolidfuel,bothindoorsandoutdoors. ,...rqualitytomorrow,"saidJackBroadbent,executiveoffic...espectthehealthoftheirneighborsandfellowcommunitym...
(Date:11/25/2009)...hers have found evidence of a statistically signif...ng patients whose estrogen receptor (ER)-positive ...pha; at serine-118 (ER-alpha S118-P), according to...5 in the Journal of the National Cancer Institute...resistant to tamoxifen. Preclinical studies have s...
(Date:11/25/2009)... follow-up period was too short to draw definite c... Nov. 25 (HealthDay News) -- In diabetic patients ...e no difference in outcomes at one year whether pa...stenting, British researchers report. , Bypass ...ic patients with coronary artery disease. However,...
(Date:11/25/2009)...forgetfulness could lead mothers to overlook neede...25 (HealthDay News) -- A mother,s depression can w...und. , Their six-month study of 262 black mothe...thers had more depressive symptoms had more freque... fewer depressive symptoms had less frequent asthm...
Breaking Medicine News(10 mins):Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Mom's Depression May Worsen Child's Asthma 2
... 18 Sales leaders and,organizations that regularl...e art of motivating their sales representatives. O... sales personnel can use the key findings,discover... Best Practices, LLC conducted this benchmark stud...
...e following is being,issued by the American Hospit...nd Coalition of Full Service Community Hospitals:,... self-referral and the,conflict of interest it cre...ssed a ban on physician self-referral to,hospitals...
...ght now, about half of all people who take medicin...it. And doctors have no definitive way to predict ...iety prescription they write. , But a University...ing the connection between brain activity, genetic...
...8 QMed, Inc.,(Nasdaq: QMED ) today announced tha...ter dated April 14, 2008, notifying the Company th...e 4350(i)(1)(A) due to its,failure to comply with ...eting the financing in violation of shareholder,ap...
... diminished depression almost as much as drug trea...s) -- Talk therapy can help treat depression sympt... Japanese researchers who reviewed the results of ... was supportive expressive group therapy, in which...
...foods have staying power,according to a new report...he U.S. The soy food and beverage market topped $2...snack bar and soymilk products. Sales of soy,foods...gh 2012, rounding out at $3 billion., Having been...
Other Medicine News:Health News:Complementary Excerpt Available from Best Practices: Rewarding and Recognizing Top-Performing Sales People 2Health News:Statement: Congress Should Include the Physician Self-Referral Provision in the Farm Bill for Patients and Communities 2Health News:High anxiety? 2Health News:High anxiety? 3Health News:High anxiety? 4Health News:QMed, Inc. Receives NASDAQ Delisting Letter 2Health News:QMed, Inc. Receives NASDAQ Delisting Letter 3Health News:Talk Therapy Proves Effective for Terminal Cancer Patients 2Health News:Soy Foods Beat Out Fresh Fish and Meat for 'Best New Products Tried By Consumers' While Demand and Profits Continue to Grow 2
(Date:11/25/2009)...irstCall/--AmericanScientificResourcesInc.(PinkShe...haveopenedaregionalmarketingandproductionmanagemen...urealocationabroad,providinganessentialgatewayfort...andsafetyproductsforchildrenandadultstobedistribut...ryinthestateofOhiowheretheywillalsobeabletodosubco...
(Date:11/25/2009)...5/PRNewswire/-- FromNovember16-18,Phonak,theleadin...dthesecondeditionoftheHearingCareforAdultsConferen...heconferencebroughttogetherleadingexpertsinagingan...nswhoworkeverydaywitholderpeoplewithhearinglossfor...researchandtrendsinhearingcareforolderpeople. ,...
(Date:11/25/2009)...swire/--AMPACFineChemicalsLLC(AFC),asubsidiaryofAm...daythatitreceivedtheEnvironmentalResponsibilityand...alSummit,sponsoredbytheCaliforniaManufacturersandT...talAssociation(IEA)andtheChemicalIndustryCouncilof...giousawardavailablefromallthreeorganizationsandgai...
Breaking Medicine Technology:American Scientific Resources Inc. Opens Shanghai Location 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Dr Christopher Olivia Appointed to Foundation Radiology Group Board of Directors 52779 1Dr Christopher Olivia Appointed to Foundation Radiology Group Board of Directors 52779 2Dr Christopher Olivia Appointed to Foundation Radiology Group Board of Directors 52779 3Diplomat Specialty Pharmacy Receives Regional Good Neighbor Pharmacy Of The Year Award 52775 1Diplomat Specialty Pharmacy Receives Regional Good Neighbor Pharmacy Of The Year Award 52775 2PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 1PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 2PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 3PharmAthene Inc Announces 2419 3 Million Private Placement of Convertible Notes and Common Stock Warrants 52772 4
...he Treatment of Inflammatory ...Payment from Partner GlaxoSmithKline, MOUNTAIN VI...unced the initiation of a Phase I clinical trial o...e compound designed to specifically,target the CCR...ammatory,diseases such as rheumatoid arthritis. Wi...
...i Corporation (,Iomai,) in a, fully recommended sh...ai,s common stock representing a fully diluted e...llion (EUR 122 million). Acquisition to be, accomp...imately 41 percent of Iomai,s current shares outs...ly 1.7 million Intercell shares (representing appr...
Other Medicine Technology:ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 2ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 3ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 4ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 5Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 2Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 3Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 4Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 5Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 6Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 7Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 8Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 9Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 10Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 11
Basic modular VICTOR2 Multilabel Counter (3 technologies)
Manual VICTOR2 with fluorescence, fluorescence polarization and luminescence technologies
VICTOR2 V (5 technologies) with stackers and robotic loading
VICTOR2 multilabel counter with IR, high density TR-fluorometry, stacker and robot loading
Medicine Products: